Aficamten
BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo’s Wegovy

BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo’s Wegovy

PharmaCompass wishes its readers a very Happy New Year and brings news from the last two weeks in this double-dose edition of...

Impressions : 1621

France draws US$ 2.25 bn investment from Big Pharma; Sanofi strikes US$ 1.2 bn deal with Novavax

France draws US$ 2.25 bn investment from Big Pharma; Sanofi strikes US$ 1.2 bn deal with Novavax

In this week’s news, France attracted investments from pharma majors such as Sanofi, Pfizer, AstraZeneca and GSK during t...

Impressions : 1168

Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod

Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod

This week’s Phispers brings you news from the annual World Economic Forum in Davos (Switzerland) where some senior execut...

Impressions : 2137

FDA allows Florida to import drugs from Canada; India mandates new GMP standards for drugmakers

FDA allows Florida to import drugs from Canada; India mandates new GMP standards for drugmakers

In this week’s Phispers, the United States Food and Drug Administration (FDA) has allowed the state of Florida to import ...

Impressions : 1619